Physician profile
Patrick C Nolan
NPI 1841254331
$1,617.11
in general payments reported to CMS, 2019-2025
22 companies · $190 in 2025
The $190 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29.39 · 2020: $24.57 · 2021: $856 · 2022: $373 · 2023: $111 · 2024: $33.53 · 2025: $190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $281.16 | 2022 | |
| Amgen INC. | $173.71 | 2021-2025 | Uplizna |
| Genzyme Corporation | $161.17 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $139.00 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $118.54 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $115.88 | 2025 | Austedo Xr |
| Abbvie INC. | $115.22 | 2021-2022 | |
| Biogen, INC. | $98.52 | 2021-2023 | Tysabri, Vumerity |
| Emd Serono, INC. | $72.85 | 2021 | |
| Alnylam Pharmaceuticals INC. | $46.26 | 2021 | |
| Adamas Pharmaceuticals, INC. | $42.27 | 2021 | |
| Eisai INC. | $36.24 | 2021 | |
| Lilly USA, LLC | $35.51 | 2019-2021 | |
| Genentech USA, INC. | $34.07 | 2023 | Ocrevus |
| Ucb, INC. | $24.57 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $22.88 | 2023 | Soliris |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.39 | 2022 | |
| Allergan, INC. | $19.32 | 2022 | |
| Neurelis, INC. | $19.31 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.94 | 2021 | |
| Biodelivery Sciences International, INC. | $13.25 | 2021 | |
| Abbott Laboratories | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Nolan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.